| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shih-Ku Lin, Chih-Ken Chen, Yu-Li Li. Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia. Journal of clinical psychopharmacology. vol 31. issue 6. 2012-02-22. PMID:22020350. |
aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia. |
2012-02-22 |
2023-08-12 |
Not clear |
| Shih-Ku Lin, Chih-Ken Chen, Yu-Li Li. Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia. Journal of clinical psychopharmacology. vol 31. issue 6. 2012-02-22. PMID:22020350. |
aripiprazole is widely used to treat schizophrenia. |
2012-02-22 |
2023-08-12 |
Not clear |
| Shih-Ku Lin, Chih-Ken Chen, Yu-Li Li. Aripiprazole and dehydroaripiprazole plasma concentrations and clinical responses in patients with schizophrenia. Journal of clinical psychopharmacology. vol 31. issue 6. 2012-02-22. PMID:22020350. |
forty-five (male/female: 19/26) patients with schizophrenia were treated with aripiprazole after a washout period of at least 3 days. |
2012-02-22 |
2023-08-12 |
Not clear |
| Kinga Burda, Anna Czubak, Krzysztof Kus, Elżbieta Nowakowska, Piotr Ratajczak, Jennifer Zi. Influence of aripiprazole on the antidepressant, anxiolytic and cognitive functions of rats. Pharmacological reports : PR. vol 63. issue 4. 2012-02-10. PMID:22001977. |
we concluded that aripiprazole could be an effective antipsychotic for the treatment of patients with schizophrenia or bipolar disorder who have associated anxiety and cognitive deficits. |
2012-02-10 |
2023-08-12 |
rat |
| Nam Young Lee, Se Hyun Kim, Dong Chung Jung, Eun Young Kim, Han Young Yu, Ki Hye Sung, Ung Gu Kang, Yong Min Ahn, Yong Sik Ki. The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 5. 2012-01-19. PMID:21513765. |
the prevalence of metabolic syndrome in korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. |
2012-01-19 |
2023-08-12 |
Not clear |
| Nam Young Lee, Se Hyun Kim, Dong Chung Jung, Eun Young Kim, Han Young Yu, Ki Hye Sung, Ung Gu Kang, Yong Min Ahn, Yong Sik Ki. The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 5. 2012-01-19. PMID:21513765. |
we reviewed the electronic medical records of patients with schizophrenia who received aripiprazole, olanzapine or risperidone monotherapies for at least three months. |
2012-01-19 |
2023-08-12 |
Not clear |
| Nam Young Lee, Se Hyun Kim, Dong Chung Jung, Eun Young Kim, Han Young Yu, Ki Hye Sung, Ung Gu Kang, Yong Min Ahn, Yong Sik Ki. The prevalence of metabolic syndrome in Korean patients with schizophrenia receiving a monotherapy with aripiprazole, olanzapine or risperidone. Progress in neuro-psychopharmacology & biological psychiatry. vol 35. issue 5. 2012-01-19. PMID:21513765. |
in conclusion, only male korean patients with schizophrenia who received a monotherapy of aripiprazole, olanzapine or risperidone for more than three months were more likely to have mets than the general population. |
2012-01-19 |
2023-08-12 |
Not clear |
| F Kasteng, J Eriksson, K Sennfält, P Lindgre. Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. Acta psychiatrica Scandinavica. vol 124. issue 3. 2012-01-17. PMID:21609324. |
metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. |
2012-01-17 |
2023-08-12 |
Not clear |
| F Kasteng, J Eriksson, K Sennfält, P Lindgre. Metabolic effects and cost-effectiveness of aripiprazole versus olanzapine in schizophrenia and bipolar disorder. Acta psychiatrica Scandinavica. vol 124. issue 3. 2012-01-17. PMID:21609324. |
to assess the cost-effectiveness of aripiprazole versus olanzapine in the treatment of patients with schizophrenia or bipolar disorder in sweden with focus on the metabolic impact of the treatments. |
2012-01-17 |
2023-08-12 |
Not clear |
| Xiaofeng Guo, Jinguo Zhai, Qinling Wei, Elizabeth W Twamley, Hua Jin, Maosheng Fang, Maorong Hu, Jingping Zha. Neurocognitive effects of first- and second-generation antipsychotic drugs in early-stage schizophrenia: a naturalistic 12-month follow-up study. Neuroscience letters. vol 503. issue 2. 2012-01-13. PMID:21888948. |
in a 12-month, open-label, multicenter study, 698 patients with early-stage schizophrenia (duration of illness ≤5 years) were prescribed chlorpromazine, sulpiride, clozapine, risperidone, olanzapine, quetiapine, or aripiprazole monotherapy. |
2012-01-13 |
2023-08-12 |
Not clear |
| Ragy R Girgis, David B Merrill, Stanislav R Vorel, Edward Kim, Kimberly Portland, Min You, Andrei Pikalov, Richard Whitehead, Jeffrey A Lieberma. Aripiprazole versus haloperidol treatment in early-stage schizophrenia. Journal of psychiatric research. vol 45. issue 6. 2011-12-27. PMID:20937506. |
aripiprazole versus haloperidol treatment in early-stage schizophrenia. |
2011-12-27 |
2023-08-12 |
human |
| Ragy R Girgis, David B Merrill, Stanislav R Vorel, Edward Kim, Kimberly Portland, Min You, Andrei Pikalov, Richard Whitehead, Jeffrey A Lieberma. Aripiprazole versus haloperidol treatment in early-stage schizophrenia. Journal of psychiatric research. vol 45. issue 6. 2011-12-27. PMID:20937506. |
we conducted a secondary analysis of a completed study of the differential efficacy and side effects of aripiprazole versus haloperidol in early-stage schizophrenia (ess), a subpopulation of patients which does not include first episode or chronic patients. |
2011-12-27 |
2023-08-12 |
human |
| Ragy R Girgis, David B Merrill, Stanislav R Vorel, Edward Kim, Kimberly Portland, Min You, Andrei Pikalov, Richard Whitehead, Jeffrey A Lieberma. Aripiprazole versus haloperidol treatment in early-stage schizophrenia. Journal of psychiatric research. vol 45. issue 6. 2011-12-27. PMID:20937506. |
a subpopulation of 360 individuals with ess were identified from a randomized, multi-center, double-blind study of 1294 individuals with schizophrenia at different stages of illness who were randomized to treatment with aripiprazole (ess = 237) or haloperidol (ess = 123) for one year. |
2011-12-27 |
2023-08-12 |
human |
| Johann Guillemot, Marie-Amélie Lukaszewski, Valérie Montel, Fabien Delahaye, Sylvain Mayeur, Christine Laborie, Anne Dickes-Coopman, Isabelle Dutriez-Casteloot, Jean Lesage, Christophe Breton, Didier Viea. Influence of prenatal undernutrition on the effects of clozapine and aripiprazole in the adult male rats: relevance to a neurodevelopmental origin of schizophrenia? European journal of pharmacology. vol 667. issue 1-3. 2011-12-27. PMID:21514291. |
influence of prenatal undernutrition on the effects of clozapine and aripiprazole in the adult male rats: relevance to a neurodevelopmental origin of schizophrenia? |
2011-12-27 |
2023-08-12 |
rat |
| Johann Guillemot, Christine Laborie, Isabelle Dutriez-Casteloot, Michel Maron, Sylvie Deloof, Jean Lesage, Christophe Breton, Didier Viea. Could maternal perinatal atypical antipsychotic treatments program later metabolic diseases in the offspring? European journal of pharmacology. vol 667. issue 1-3. 2011-12-27. PMID:21664905. |
we have recently reported that rat offspring from prenatally undernourished mothers exhibit a low birth weight associated with modified sensitivity to clozapine and aripiprazole in adulthood reinforcing the idea that some forms of schizophrenia may be acquired during early development. |
2011-12-27 |
2023-08-12 |
rat |
| W Wolfgang Fleischhacker, Martti E Heikkinen, Jean-Pierre Olié, Wally Landsberg, Patricia Dewaele, Robert D McQuade, Jean-Yves Loze, Delphine Hennicken, Wendy Kerselaer. Effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. The international journal of neuropsychopharmacology. vol 13. issue 8. 2011-12-19. PMID:20459883. |
effects of adjunctive treatment with aripiprazole on body weight and clinical efficacy in schizophrenia patients treated with clozapine: a randomized, double-blind, placebo-controlled trial. |
2011-12-19 |
2023-08-12 |
Not clear |
| Julien Cohen, David Magalon, Laurent Boyer, Nicolas Simon, Lançon Christoph. Aripiprazole-induced pathological gambling: a report of 3 cases. Current drug safety. vol 6. issue 1. 2011-12-12. PMID:21241242. |
we report three cases of pathological gambling induced by aripiprazole, in patients with schizophrenia or schizoaffective disorder. |
2011-12-12 |
2023-08-12 |
Not clear |
| Kenneth N Sokolsk. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia. The Annals of pharmacotherapy. vol 45. issue 7-8. 2011-12-07. PMID:21672885. |
combination loxapine and aripiprazole for refractory hallucinations in schizophrenia. |
2011-12-07 |
2023-08-12 |
Not clear |
| Kenneth N Sokolsk. Combination loxapine and aripiprazole for refractory hallucinations in schizophrenia. The Annals of pharmacotherapy. vol 45. issue 7-8. 2011-12-07. PMID:21672885. |
to document the effects of combining loxapine with aripiprazole for refractory hallucinations in 2 patients with chronic schizophrenia. |
2011-12-07 |
2023-08-12 |
Not clear |
| Yi-Wei Ye. Persistent hiccups associated with switching from risperidone to aripiprazole in a schizophrenic patient with cerebral palsy. Clinical neuropharmacology. vol 34. issue 4. 2011-12-07. PMID:21768798. |
we report a case of persistent hiccups after administration of aripiprazole in a patient with concurrence of schizophrenia and cerebral palsy. |
2011-12-07 |
2023-08-12 |
Not clear |